Latest / Morning Medical with Dr. Chow / Type 1 Diabetes & Dementia, Beauty Parlor Stroke, and AI in Breast Cancer Screening

Transcript

Type 1 Diabetes & Dementia, Beauty Parlor Stroke, and AI in Breast Cancer Screening · Morning Medical with Dr. Chow

• 0:00
  Welcome to Morning Medical with Doctor Chow, your daily dose of the latest medical and
• 0:04
  health news from around the world, powered by artificial intelligence.
• 0:08
  I am Doctor Chi-Ming Chow, a family physician, general internist, and cardiologist, coming to
• 0:14
  you from Toronto, Ontario, Canada.
• 0:17
  Today, we're diving into a fascinating study that highlights the growing concerns about
• 0:21
  dementia in patients with type 1 diabetes as they live longer.
• 0:28
  A recent study has brought to light a significant concern for older individuals
• 0:32
  living with type 1 diabetes.
• 0:35
  It turns out they have a nearly threefold higher risk of developing dementia compared to
• 0:40
  those without diabetes.
• 0:42
  This study, conducted in the United States, was a prospective cohort study that followed
• 0:48
  participants over a 2.4-year period.
• 0:51
  Researchers adjusted for sociodemographic factors and found that older adults with type 1
• 0:57
  diabetes had a hazard ratio of 2.82 for incident all-cause dementia.
• 1:03
  To put it simply, these individuals were nearly three times more likely to develop dementia.
• 1:11
  The researchers involved in this study, including Jennifer Weuve from the Boston
• 1:15
  University School of Public Health, have emphasized the unique dementia risks that type
• 1:20
  1 diabetes presents.
• 1:22
  Unlike type 2 diabetes, which is linked to dementia through factors like hyperglycemia and
• 1:27
  metabolic syndrome, type 1 diabetes might increase dementia risk through different
• 1:32
  mechanisms.
• 1:33
  These could include hypoglycemic events that cause neuronal damage or altered glucose
• 1:39
  metabolism.
• 1:41
  As medical care has advanced, people with type 1 diabetes are living longer, which makes
• 1:46
  understanding the relationship between type 1 diabetes and dementia risk increasingly
• 1:51
  important.
• 1:53
  While type 1 diabetes is not as common as type 2, the number of people over 65 with this
• 1:59
  condition is growing, underscoring the urgency of addressing this issue.
• 2:04
  The study found that approximately 64.5% of dementia cases in people with type 1 diabetes
• 2:13
  could be attributed to their condition.
• 2:16
  The data for this research came from the ongoing longitudinal All of Us cohort, which
• 2:21
  began in 2017.
• 2:23
  It included over 283,000 participants, with around 5,400 individuals having type 1
• 2:31
  diabetes.
• 2:33
  The study found that both women and men with type 1 diabetes had a higher risk for dementia,
• 2:38
  and this elevated risk was consistent across different race and ethnic groups.
• 2:43
  One interesting point raised by the researchers was the potential for surveillance bias.
• 2:49
  Individuals with type 1 diabetes often have more frequent interactions with healthcare
• 2:53
  systems, which might increase the likelihood of receiving an earlier dementia diagnosis.
• 2:59
  Nonetheless, the findings of this study are crucial as they highlight the need for better
• 3:04
  dementia prevention strategies specifically tailored for those with type 1 diabetes.
• 3:12
  Today, we're exploring a surprising and rare medical condition known as beauty parlor stroke
• 3:17
  syndrome.
• 3:17
  This condition might sound whimsical, but it can have serious consequences, leading to a
• 3:23
  vertebral artery stroke due to compression of the blood vessels at the back of the head.
• 3:27
  This scenario can arise from something as seemingly benign as getting your hair washed at
• 3:32
  a salon.
• 3:33
  Dr.
• 3:33
  Anna Hohler, director of neurology for Northwell Health's Westchester Region, explains
• 3:38
  that hyperextending the neck during a prolonged hair wash can compress the vertebral arteries,
• 3:44
  reducing blood flow to the brain stem, and potentially leading to a stroke.
• 3:50
  While this condition most commonly affects older individuals, it can occur in younger
• 3:55
  people, particularly those with connective tissue disorders like Ehlers-Danlos Syndrome,
• 4:00
  which predispose them to blood vessel tearing or dissection.
• 4:05
  High cholesterol and other stroke risk factors also increase the likelihood of experiencing
• 4:11
  beauty parlor stroke syndrome.
• 4:13
  A literature review in The American Journal of Emergency Medicine highlights that most
• 4:18
  reported cases occur in women.
• 4:21
  Despite its name, this syndrome can result from various situations, such as chiropractic
• 4:26
  manipulation, whiplash from car accidents, snowboarding, skiing, martial arts, and even
• 4:32
  bungee jumping.
• 4:34
  Dr.
• 4:35
  Hohler notes that while she has only encountered one classic case of beauty parlor
• 4:40
  stroke syndrome from a salon visit, she has seen more cases arising from other
• 4:45
  circumstances.
• 4:46
  The condition can result from both mechanical triggers, like compression or shearing of the
• 4:51
  blood vessels, and physiological triggers, such as cholesterol buildup affecting circulation.
• 4:57
  If you experience sudden-onset neurological symptoms, such as dizziness or numbness after a
• 5:02
  hair wash or any physical activity, it is crucial to seek immediate emergency care.
• 5:08
  This would likely involve a neurology consultation to rule out other conditions, like
• 5:13
  migraines or multiple sclerosis, that may present similarly.
• 5:18
  The diagnosis of beauty parlor stroke syndrome may sound lighthearted, but the implications
• 5:23
  are serious.
• 5:25
  The brain stem, where these strokes often occur, controls essential functions, including
• 5:30
  cognitive, motor, and sensory operations.
• 5:34
  Emergency department evaluations typically involve a CT scan with blood vessel imaging and
• 5:39
  an MRI to pinpoint the stroke area.
• 5:43
  In some cases, simply repositioning the head can alleviate symptoms, but more severe cases
• 5:49
  might require treatments like clot-busting drugs, antiplatelet therapy, or aspirin.
• 5:56
  Unfortunately, in severe instances, particularly when the blood vessel dissection
• 6:00
  is prolonged, the syndrome can be fatal or leave patients with lasting deficits, such as
• 6:06
  issues with balance or coordination.
• 6:09
  Patients who have experienced beauty parlor stroke syndrome are at risk for recurrence, so
• 6:14
  they are advised to avoid the activity that triggered the event.
• 6:17
  Those with significant blockage from high cholesterol or other risk factors might face
• 6:22
  similar troubles in other parts of the brain.
• 6:25
  Emergency room assessments and imaging can help identify any underlying conditions, such as
• 6:31
  connective tissue disorders, that may further increase the risk of blood vessel dissections.
• 6:37
  As salons become more aware of the risks associated with beauty parlor stroke syndrome,
• 6:42
  many now inquire about clients' ability to extend their necks.
• 6:46
  Additionally, some have redesigned hair washing stations to minimize neck strain, enhancing
• 6:52
  safety during what should be a relaxing salon visit.
• 6:56
  Let's delve into a fascinating development in the realm of breast cancer screening.
• 7:02
  A recent study has suggested that a partially autonomous artificial intelligence approach
• 7:08
  could significantly reduce the need for radiologist review of low-risk mammograms.
• 7:14
  This innovative strategy not only decreased radiologist workload by nearly 64 percent but
• 7:20
  also increased the cancer detection rate by over 15 percent compared to the standard
• 7:24
  double-blind reading method.
• 7:27
  The study was conducted as a prospective noninferiority trial, meaning it aimed to
• 7:33
  demonstrate that the artificial intelligence-supported method was not inferior
• 7:38
  to the traditional approach.
• 7:40
  In this trial, mammograms classified by artificial intelligence as low risk were
• 7:46
  automatically assessed as normal, eliminating the need for a radiologist's review, while the
• 7:51
  remaining cases were double-read with artificial intelligence support.
• 7:56
  This approach led to a significant reduction in the radiologist's workload, as reported by
• 8:02
  Esperanza Elías-Cabot, M.D., and her colleagues from the Reina Sofía University Hospital in
• 8:08
  Spain.
• 8:10
  Interestingly, the artificial intelligence strategy not only reduced workload but also
• 8:16
  increased the cancer detection rate by 15.2 percent, with an absolute difference of 1.0 per
• 8:22
  1,000 exams.
• 8:24
  However, it's important to note that the recall rate was slightly higher with the artificial
• 8:29
  intelligence strategy, increasing by 0.7 percent.
• 8:33
  This aspect did not meet the noninferiority criteria when compared to the standard
• 8:37
  strategy.
• 8:39
  The researchers highlighted the impressive accuracy of artificial intelligence in
• 8:44
  identifying low-risk breast screening exams.
• 8:48
  They noted that artificial intelligence's high negative predictive value could allow for
• 8:53
  completely autonomous reading of exams deemed very likely normal.
• 8:58
  However, the ethical challenges of excluding radiologists from reviewing most mammograms
• 9:04
  remain a significant barrier to clinical adoption.
• 9:07
  Concerns include the possibility of missing cancers, although the study found that more
• 9:12
  cancers were missed by radiologists when artificial intelligence was not used for
• 9:17
  decision support.
• 9:19
  The authors of the study stressed the need for additional quality assurance processes before
• 9:24
  implementing such an autonomous artificial intelligence screening workflow.
• 9:28
  These would include automated mammography image quality control and continuous post-market
• 9:34
  surveillance of artificial intelligence performance.
• 9:36
  The study's objective was to confirm that an artificial intelligence system could safely
• 9:41
  omit human reading for a large portion of low-risk screening exams.
• 9:46
  The trial involved over 31,000 women, with a median age of 59, and was conducted at a single
• 9:53
  site in Spain.
• 9:55
  The participants underwent either digital mammography or digital breast tomosynthesis.
• 10:01
  The findings showed that while the positive predictive value was similar for both
• 10:05
  strategies, the artificial intelligence approach had a slightly higher false-positive
• 10:10
  rate.
• 10:11
  Additionally, workload reductions were significant for both digital mammography and
• 10:16
  digital breast tomosynthesis, but the cancer detection rate was notably higher with digital
• 10:22
  mammography when using artificial intelligence.
• 10:26
  Despite these promising results, the ethical implications of reducing radiologist
• 10:31
  involvement must be carefully considered.
• 10:34
  The study underscores the potential of artificial intelligence to enhance screening
• 10:39
  programs, particularly through the significant workload reduction it offers.
• 10:44
  However, implementing such technology requires a careful balance between efficiency and the
• 10:49
  ethical responsibility to ensure comprehensive cancer detection.
• 10:56
  Ontario is taking a significant step towards revolutionizing its healthcare system by
• 11:01
  planning to create a provincewide electronic medical record system for primary care.
• 11:07
  This initiative comes over two decades after the government first attempted to establish
• 11:11
  such a system, which had previously ended in a scandal-ridden eHealth project.
• 11:17
  Health Minister Sylvia Jones announced that the province will start by engaging with potential
• 11:22
  vendors to explore what can be achieved.
• 11:25
  The goal is to evaluate the capacity of vendors to handle this extensive project.
• 11:31
  Minister Jones emphasized the importance of ensuring that various systems, whether in
• 11:36
  hospitals, laboratories, or physicians' offices, can communicate effectively.
• 11:42
  This initiative aims to benefit both patients and primary care providers by allowing
• 11:47
  comprehensive access to medical histories, which can be crucial in emergency situations.
• 11:54
  Doctor Jane Philpott, chair of Ontario's primary care action team and a family doctor by
• 11:58
  training, highlighted the importance of having a connected medical record system.
• 12:03
  She explained that when a patient's medical history is not readily available, it can create
• 12:08
  significant challenges.
• 12:10
  Patients deserve for everyone involved in their care to have a complete view of their health
• 12:14
  information, including allergies, medications, vaccinations, and test results.
• 12:21
  Missing information can lead to safety risks, unnecessary repeat tests, and delays in care.
• 12:28
  Currently, most primary care providers use electronic records, but these systems are often
• 12:34
  isolated.
• 12:36
  Minister Jones pointed out the need to expand these systems to include lab results, hospital
• 12:42
  visits, and interactions with Ontario Health at Home and home care workers.
• 12:47
  This holistic approach aims to ensure that all relevant health information is consolidated
• 12:52
  into a single accessible record.
• 12:55
  As of now, government officials have not provided a cost estimate for this system, as
• 13:00
  they are still in the preliminary stages of a market sounding exercise.
• 13:04
  Ontario's initial efforts to create integrated electronic medical records began in the early
• 13:10
  2000s but faced setbacks, including a 2009 scandal where the eHealth agency spent one
• 13:17
  billion dollars with little progress.
• 13:20
  A follow-up report in 2016 indicated that eight billion dollars had been spent on various
• 13:27
  electronic health record initiatives by that time.
• 13:30
  The new system's rollout will be voluntary for both health professionals and patients, with
• 13:35
  the government considering ways to support doctors financially as they transition to the
• 13:39
  new records.
• 13:40
  However, opposition health critics have expressed skepticism about the rollout under
• 13:44
  Premier Doug Ford's government, citing concerns about patient data security and privacy,
• 13:49
  particularly after a privacy breach involving home care patients' data last year.
• 13:54
  Liberal health critic Adil Shamji voiced concerns about the lack of a clear timeline for
• 14:00
  implementation and the potential for repeating past mistakes, as seen with Ontario Health at
• 14:06
  Home.
• 14:07
  Meanwhile, NDP health critic Robin Lennox, also a family doctor, acknowledged the idea's
• 14:13
  potential but stressed the need for seamless implementation to reduce administrative burdens
• 14:18
  on doctors.
• 14:20
  As the province moves forward with this initiative, government officials have
• 14:24
  reiterated that participation in the new system will remain voluntary.
• 14:29
  In addition to this, Finance Minister Peter Bethlenfalvy announced that the upcoming
• 14:34
  provincial budget will allocate an additional three hundred twenty-five million dollars for
• 14:38
  primary care.
• 14:40
  This investment aligns with the government's goal of ensuring every resident in Ontario has
• 14:45
  access to a primary care provider by 2029.
• 14:50
  In an exciting development for those managing obesity, the United States Food and Drug
• 14:55
  Administration has granted approval for a higher dose of the semaglutide injectable,
• 15:00
  known as Wegovy HD.
• 15:04
  This new 7.2-milligram dose is designed for patients who have been unable to achieve their
• 15:09
  weight loss goals with the existing 2.4-milligram dose.
• 15:15
  This once-weekly injection is intended for adults battling obesity who have tolerated the
• 15:21
  lower dose for at least four weeks and need further assistance in losing weight.
• 15:26
  It's important to note that this treatment should be used in conjunction with a
• 15:30
  low-calorie diet and increased physical activity.
• 15:34
  Semaglutide, a GLP-1 receptor agonist, has already been recognized for its role in
• 15:40
  reducing the risk of major adverse cardiovascular events and treating metabolic
• 15:44
  dysfunction-associated steatohepatitis, also known as MASH.
• 15:49
  The introduction of Wegovy HD provides a vital new option in the arsenal against obesity,
• 15:55
  offering healthcare providers the ability to tailor treatment strategies more effectively.
• 16:00
  Doctor W.
• 16:00
  Timothy Garvey, a renowned investigator from the Diabetes Research Center at the University
• 16:05
  of Alabama at Birmingham, expressed optimism that the weight loss results seen with Wegovy
• 16:12
  HD could redefine expectations for patient outcomes.
• 16:17
  The STEP UP trial, which played a key role in this approval, demonstrated remarkable results.
• 16:26
  Adults without type 2 diabetes who received the 7.2-milligram dose of semaglutide lost an
• 16:32
  impressive average of 19 percent of their body weight.
• 16:36
  This was a significant improvement compared to those on the 2.4-milligram dose, who lost 16
• 16:42
  percent, and those on a placebo, who lost only 3.9 percent.
• 16:47
  Notably, participants who adhered strictly to the 7.2-milligram regimen experienced a 21
• 16:53
  percent reduction in body weight, with 31 percent of them losing at least a quarter of
• 16:58
  their body weight.
• 17:00
  As with any medication, there are potential side effects.
• 17:04
  Common adverse reactions associated with the 7.2-milligram dose include nausea, vomiting,
• 17:10
  dysesthesia, constipation, abdominal pain, fatigue, headache, dizziness, hair loss, and
• 17:17
  flatulence.
• 17:19
  It's noteworthy that dysesthesia, a condition marked by abnormal skin sensations, was more
• 17:24
  prevalent among those on the higher dose compared to the lower dose.
• 17:29
  In fact, 22 percent of participants on the 7.2-milligram dose experienced altered skin
• 17:36
  sensations, compared to just 6 percent on the 2.4-milligram dose.
• 17:42
  The Food and Drug Administration is currently investigating this particular reaction further.
• 17:48
  The approval of Wegovy HD also comes with a boxed warning regarding the risk of thyroid
• 17:53
  C-cell tumors.
• 17:54
  As a result, it is contraindicated for patients with a personal or family history of medullary
• 17:59
  thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
• 18:04
  Beyond the injectable form, semaglutide is also available as a once-daily 25-milligram pill,
• 18:10
  which received approval in December 2025.
• 18:13
  The swift approval of Wegovy HD, achieved within just 54 days of filing, marks it as the
• 18:19
  fourth approval under the FDA Commissioner's National Priority Voucher pilot program.
• 18:24
  This new option is expected to be available starting in April, according to Novo Nordisk.
• 18:30
  That's all for today's episode of Morning Medical with Doctor Chow.
• 18:33
  I hope you found these updates insightful and informative.
• 18:37
  As always, stay tuned for more medical news and advancements from around the world.
• 18:42
  Until next time, this is Doctor Chi-Ming Chow, wishing you a healthy and informed day.